Looking for New Targeted Therapies for Osteosarcoma
Researchers will investigate the role of a signaling pathway in the progression of bone cancer in dogs and evaluate its potential as a new therapeutic target to help treat this disease.
Displaying 31 - 40 of 299 results
Assessing Immune Stimulation as a Potential Therapy for Osteosarcoma
This study will characterize the expression of toll-like receptors, which activate the immune system, in canine osteosarcoma cells to better determine the biological consequences associated with activating these receptors.
Finding Solutions for Giant-Breed Dogs with Osteosarcoma
Researchers are creating tools to estimate fracture risk in giant-breed dogs with osteosarcoma as well as evaluating a novel method to stabilize the affected bone.
Morris Animal Foundation Presents Golden Retriever Lifetime Study at Guisachan Gathering in Scotland
July 3, 2018 – The Foundation’s Acting President/CEO Tiffany Grunert will make a presentation to introduce the study during The Golden Retriever Club of Scotland’s Guisachan Gathering.
Latest Call for Proposals to Use Golden Retriever Lifetime Study Data
November 15, 2023 — Morris Animal Foundation is now accepting research proposals for access to data and/or biological samples collected as part of its Golden Retriever Lifetime Study.
Caring For Study Members is This Participant’s Mission
May 5, 2022 – Study participant Gail Ingrish talks about her experience as Study participant and volunteer.
Determining How Overexpression of miR-9 Helps Osteosarcoma Spread
This study will provide a molecular framework for understanding the process of miR-9-driven tumor spread in canine osteosarcoma, thereby generating potential new targets for therapy to prevent or treat tumor spread in this devastating disease.
Merging Therapies to Improve Osteosarcoma Outcomes
SUMMARY: Researchers will study whether a combination of targeted radiation therapy and a novel immune cell homing material can provide body-wide protection against osteosarcoma. THE PROBLEM: Osteosarcoma (OS) is the...
Evaluating the Effectiveness of an Adjunct Therapy in Dogs with Osteosarcoma
Researchers are evaluating the effectiveness of oral rapamycin as an adjunct, postsurgery therapy to combat cancer spread (metastasis) in client-owned dogs.
Combining Therapies to Improve Osteosarcoma Treatment
SUMMARY: Researchers will study whether a combination of oral medication and new tumor vaccine provide survival benefit for dogs diagnosed with osteosarcoma. THE PROBLEM: Osteosarcoma (OS) is the most common...